OM-X®, Fermented Vegetables Extract Suppresses Antigen-Stimulated Degranulation in Rat Basophilic Leukemia RBL-2H3 Cells and Passive Cutaneous Anaphylaxis Reaction in Mice. 2015

Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata

OM-X® is a hand-made and naturally manufactured probiotic supplement. This fermented food product is made from vegetables, fruits, seaweeds and mushrooms, using 12 strains of lactic acid bacteria and bifidobacteria. OM-X® is also known to have beneficial health properties, and some of its components show effects on antigen (Ag)-stimulated degranulation activity, indicating that OM-X® may be useful in the treatment of allergy responses and symptoms. In this study, we evaluated the inhibitory effects of OM-X® on Ag-stimulated degranulation in rat basophilic leukemia RBL-2H3 cells, clarified the underlying mechanisms, and determined the active compounds in OM-X® for suppression of degranulation. Treatment with OM-X® gradually suppressed Ag-stimulated degranulation throughout the maturation period. OM-X® also gradually produced melanoidins by lactic acid bacterial fermentation during the maturation process. There was a high correlation between the suppression levels of Ag-stimulated degranulation and the browning of OM-X®. Furthermore, the inhibition of Ag-stimulated degranulation by OM-X® was found to be partially due to the direct inactivation of NADPH oxidase. To elucidate the in vivo effects of OM- X®, type I allergy model mice were orally administered with OM-X®, and the passive cutaneous anaphylaxis (PCA) reaction was measured. OM-X® intake remarkably suppressed the PCA reaction. Taken together, our findings suggest that OMX® could be a beneficial food to ameliorate allergic reactions.

UI MeSH Term Description Entries
D008297 Male Males
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D010323 Passive Cutaneous Anaphylaxis An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. PCA is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity. Anaphylaxis, Passive Cutaneous,PCA,Cutaneous Anaphylaxis, Passive
D010851 Picrates Salts or esters of PICRIC ACID.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl
D015471 Leukemia, Basophilic, Acute A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse. Basophilic Leukemia, Acute,Acute Basophilic Leukemia,Acute Basophilic Leukemias,Basophilic Leukemias, Acute,Leukemia, Acute Basophilic,Leukemias, Acute Basophilic
D016166 Free Radical Scavengers Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. Free Radical Scavenger,Radical Scavenger, Free,Scavenger, Free Radical,Scavengers, Free Radical

Related Publications

Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata
July 2012, Phytotherapy research : PTR,
Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata
June 2010, Journal of agricultural and food chemistry,
Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata
April 2012, International immunopharmacology,
Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata
January 2016, Chemical & pharmaceutical bulletin,
Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata
January 2010, Microbiology and immunology,
Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata
January 2019, Evidence-based complementary and alternative medicine : eCAM,
Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata
April 2009, Bioorganic & medicinal chemistry,
Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata
March 2004, Journal of pharmacological sciences,
Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata
April 2019, Cytotechnology,
Tomohiro Itoh, and Yasuyoshi Miyake, and Takuya Kasashima, and Yoshie Shimomiya, and Yuki Nakamura, and Masashi Ando, and Yasuyuki Tsukamasa, and Muneaki Takahata
January 2014, Journal of oleo science,
Copied contents to your clipboard!